Background: Glial fibrillary acidic protein (GFAP) is an intermediate filament protein found in
the cytoskeleton of astroglia. Recent work has indicated that GFAP may serve as a serum …

Background: This study aimed to determine whether glial fibrillary acidic protein (GFAP) is
released after traumatic brain injury (TBI), whether GFAP is related to brain injury severity …

Background: Serum glial fibrillary acidic protein (GFAP) is a specific predictor of brain
damage and neurologic outcome in patients with traumatic brain injury (TBI). In this study …

Glial fibrillary acidic protein and its breakdown products (GFAP-BDP) are brain-specific
proteins released into serum as part of the pathophysiological response after traumatic brain …

Reliable diagnosis of traumatic brain injury (TBI) is a major public health need. Glial fibrillary
acidic protein (GFAP) is expressed in the central nervous system, and breakdown products …

STUDY OBJECTIVE: This study examines whether serum levels of glial fibrillary acidic
protein breakdown products (GFAP-BDP) are elevated in patients with mild and moderate …

Traumatic brain injuries (TBIs) are potentially lethal medical conditions, with symptoms that
can overlap with symptoms of injuries outside the brain. In many cases, current diagnostic …

Objectives: 1) To determine the levels of glial fibrillary acidic protein (GFAP) in both
cerebrospinal fluid and serum; 2) to determine whether serum GFAP levels correlate with …

AIM OF THE STUDY: Serum glial fibrillary acidic protein (GFAP) has recently been identified
as a specific predictor of brain damage and neurological outcome in patients with head …

Objective: Identification and validation of blood-based biomarkers for the diagnosis and
prognosis of mild traumatic brain injury (mTBI) is of critical importance. There have been …